The Endocrine Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Endocrine Testing market size is estimated to be worth US$ 7886.3 million in 2021 and is forecast to a readjusted size of USD 12030 million by 2028 with a CAGR of 6.2% during review period. Hospitals accounting for % of the Endocrine Testing global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tandem Mass Spectrometry segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Endocrine Testing include Abbott Laboratories, AdnaGen, Beckman Coulter/Danaher, Biomedical Diagnostics, and BioMerieux, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Endocrine Testing market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tandem Mass Spectrometry
Immunoassay
Market segment by Application, can be divided into
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
Market segment by players, this report covers
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory
Kyowa Medex
Matritech
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Endocrine Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Endocrine Testing, with revenue, gross margin and global market share of Endocrine Testing from 2019 to 2022.
Chapter 3, the Endocrine Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Endocrine Testing market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Endocrine Testing research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Endocrine Testing
1.2 Classification of Endocrine Testing by Type
1.2.1 Overview: Global Endocrine Testing Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Endocrine Testing Revenue Market Share by Type in 2021
1.2.3 Tandem Mass Spectrometry
1.2.4 Immunoassay
1.3 Global Endocrine Testing Market by Application
1.3.1 Overview: Global Endocrine Testing Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Commercial Laboratories
1.3.4 Ambulatory Care Centres
1.3.5 Other Setting
1.4 Global Endocrine Testing Market Size & Forecast
1.5 Global Endocrine Testing Market Size and Forecast by Region
1.5.1 Global Endocrine Testing Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Endocrine Testing Market Size by Region, (2017-2022)
1.5.3 North America Endocrine Testing Market Size and Prospect (2017-2028)
1.5.4 Europe Endocrine Testing Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Endocrine Testing Market Size and Prospect (2017-2028)
1.5.6 South America Endocrine Testing Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Endocrine Testing Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Endocrine Testing Market Drivers
1.6.2 Endocrine Testing Market Restraints
1.6.3 Endocrine Testing Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Endocrine Testing Product and Solutions
2.1.4 Abbott Laboratories Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 AdnaGen
2.2.1 AdnaGen Details
2.2.2 AdnaGen Major Business
2.2.3 AdnaGen Endocrine Testing Product and Solutions
2.2.4 AdnaGen Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 AdnaGen Recent Developments and Future Plans
2.3 Beckman Coulter/Danaher
2.3.1 Beckman Coulter/Danaher Details
2.3.2 Beckman Coulter/Danaher Major Business
2.3.3 Beckman Coulter/Danaher Endocrine Testing Product and Solutions
2.3.4 Beckman Coulter/Danaher Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Beckman Coulter/Danaher Recent Developments and Future Plans
2.4 Biomedical Diagnostics
2.4.1 Biomedical Diagnostics Details
2.4.2 Biomedical Diagnostics Major Business
2.4.3 Biomedical Diagnostics Endocrine Testing Product and Solutions
2.4.4 Biomedical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Biomedical Diagnostics Recent Developments and Future Plans
2.5 BioMerieux
2.5.1 BioMerieux Details
2.5.2 BioMerieux Major Business
2.5.3 BioMerieux Endocrine Testing Product and Solutions
2.5.4 BioMerieux Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 BioMerieux Recent Developments and Future Plans
2.6 Bio-Rad
2.6.1 Bio-Rad Details
2.6.2 Bio-Rad Major Business
2.6.3 Bio-Rad Endocrine Testing Product and Solutions
2.6.4 Bio-Rad Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Bio-Rad Recent Developments and Future Plans
2.7 Dako
2.7.1 Dako Details
2.7.2 Dako Major Business
2.7.3 Dako Endocrine Testing Product and Solutions
2.7.4 Dako Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Dako Recent Developments and Future Plans
2.8 DiaSorin
2.8.1 DiaSorin Details
2.8.2 DiaSorin Major Business
2.8.3 DiaSorin Endocrine Testing Product and Solutions
2.8.4 DiaSorin Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 DiaSorin Recent Developments and Future Plans
2.9 Eiken
2.9.1 Eiken Details
2.9.2 Eiken Major Business
2.9.3 Eiken Endocrine Testing Product and Solutions
2.9.4 Eiken Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Eiken Recent Developments and Future Plans
2.10 Fujirebio
2.10.1 Fujirebio Details
2.10.2 Fujirebio Major Business
2.10.3 Fujirebio Endocrine Testing Product and Solutions
2.10.4 Fujirebio Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Fujirebio Recent Developments and Future Plans
2.11 Instrumentation Laboratory
2.11.1 Instrumentation Laboratory Details
2.11.2 Instrumentation Laboratory Major Business
2.11.3 Instrumentation Laboratory Endocrine Testing Product and Solutions
2.11.4 Instrumentation Laboratory Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Instrumentation Laboratory Recent Developments and Future Plans
2.12 Kyowa Medex
2.12.1 Kyowa Medex Details
2.12.2 Kyowa Medex Major Business
2.12.3 Kyowa Medex Endocrine Testing Product and Solutions
2.12.4 Kyowa Medex Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Kyowa Medex Recent Developments and Future Plans
2.13 Matritech
2.13.1 Matritech Details
2.13.2 Matritech Major Business
2.13.3 Matritech Endocrine Testing Product and Solutions
2.13.4 Matritech Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Matritech Recent Developments and Future Plans
2.14 Ortho-Clinical Diagnostics
2.14.1 Ortho-Clinical Diagnostics Details
2.14.2 Ortho-Clinical Diagnostics Major Business
2.14.3 Ortho-Clinical Diagnostics Endocrine Testing Product and Solutions
2.14.4 Ortho-Clinical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Ortho-Clinical Diagnostics Recent Developments and Future Plans
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Endocrine Testing Product and Solutions
2.15.4 Roche Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Roche Recent Developments and Future Plans
2.16 Siemens
2.16.1 Siemens Details
2.16.2 Siemens Major Business
2.16.3 Siemens Endocrine Testing Product and Solutions
2.16.4 Siemens Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Siemens Recent Developments and Future Plans
2.17 Sysmex
2.17.1 Sysmex Details
2.17.2 Sysmex Major Business
2.17.3 Sysmex Endocrine Testing Product and Solutions
2.17.4 Sysmex Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 Sysmex Recent Developments and Future Plans
2.18 Thermo Fisher
2.18.1 Thermo Fisher Details
2.18.2 Thermo Fisher Major Business
2.18.3 Thermo Fisher Endocrine Testing Product and Solutions
2.18.4 Thermo Fisher Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 Thermo Fisher Recent Developments and Future Plans
2.19 Tosoh
2.19.1 Tosoh Details
2.19.2 Tosoh Major Business
2.19.3 Tosoh Endocrine Testing Product and Solutions
2.19.4 Tosoh Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 Tosoh Recent Developments and Future Plans
2.20 Wako
2.20.1 Wako Details
2.20.2 Wako Major Business
2.20.3 Wako Endocrine Testing Product and Solutions
2.20.4 Wako Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Wako Recent Developments and Future Plans
2.21 Wallac/PE
2.21.1 Wallac/PE Details
2.21.2 Wallac/PE Major Business
2.21.3 Wallac/PE Endocrine Testing Product and Solutions
2.21.4 Wallac/PE Endocrine Testing Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Wallac/PE Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Endocrine Testing Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Endocrine Testing Players Market Share in 2021
3.2.2 Top 10 Endocrine Testing Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Endocrine Testing Players Head Office, Products and Services Provided
3.4 Endocrine Testing Mergers & Acquisitions
3.5 Endocrine Testing New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Endocrine Testing Revenue and Market Share by Type (2017-2022)
4.2 Global Endocrine Testing Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Endocrine Testing Revenue Market Share by Application (2017-2022)
5.2 Global Endocrine Testing Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Endocrine Testing Revenue by Type (2017-2028)
6.2 North America Endocrine Testing Revenue by Application (2017-2028)
6.3 North America Endocrine Testing Market Size by Country
6.3.1 North America Endocrine Testing Revenue by Country (2017-2028)
6.3.2 United States Endocrine Testing Market Size and Forecast (2017-2028)
6.3.3 Canada Endocrine Testing Market Size and Forecast (2017-2028)
6.3.4 Mexico Endocrine Testing Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Endocrine Testing Revenue by Type (2017-2028)
7.2 Europe Endocrine Testing Revenue by Application (2017-2028)
7.3 Europe Endocrine Testing Market Size by Country
7.3.1 Europe Endocrine Testing Revenue by Country (2017-2028)
7.3.2 Germany Endocrine Testing Market Size and Forecast (2017-2028)
7.3.3 France Endocrine Testing Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Endocrine Testing Market Size and Forecast (2017-2028)
7.3.5 Russia Endocrine Testing Market Size and Forecast (2017-2028)
7.3.6 Italy Endocrine Testing Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Endocrine Testing Revenue by Type (2017-2028)
8.2 Asia-Pacific Endocrine Testing Revenue by Application (2017-2028)
8.3 Asia-Pacific Endocrine Testing Market Size by Region
8.3.1 Asia-Pacific Endocrine Testing Revenue by Region (2017-2028)
8.3.2 China Endocrine Testing Market Size and Forecast (2017-2028)
8.3.3 Japan Endocrine Testing Market Size and Forecast (2017-2028)
8.3.4 South Korea Endocrine Testing Market Size and Forecast (2017-2028)
8.3.5 India Endocrine Testing Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Endocrine Testing Market Size and Forecast (2017-2028)
8.3.7 Australia Endocrine Testing Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Endocrine Testing Revenue by Type (2017-2028)
9.2 South America Endocrine Testing Revenue by Application (2017-2028)
9.3 South America Endocrine Testing Market Size by Country
9.3.1 South America Endocrine Testing Revenue by Country (2017-2028)
9.3.2 Brazil Endocrine Testing Market Size and Forecast (2017-2028)
9.3.3 Argentina Endocrine Testing Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Endocrine Testing Revenue by Type (2017-2028)
10.2 Middle East & Africa Endocrine Testing Revenue by Application (2017-2028)
10.3 Middle East & Africa Endocrine Testing Market Size by Country
10.3.1 Middle East & Africa Endocrine Testing Revenue by Country (2017-2028)
10.3.2 Turkey Endocrine Testing Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Endocrine Testing Market Size and Forecast (2017-2028)
10.3.4 UAE Endocrine Testing Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Endocrine Testing Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Endocrine Testing Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Endocrine Testing Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Endocrine Testing Revenue (USD Million) by Region (2017-2022)
Table 5. Global Endocrine Testing Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Endocrine Testing Product and Solutions
Table 9. Abbott Laboratories Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. AdnaGen Corporate Information, Head Office, and Major Competitors
Table 11. AdnaGen Major Business
Table 12. AdnaGen Endocrine Testing Product and Solutions
Table 13. AdnaGen Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Beckman Coulter/Danaher Corporate Information, Head Office, and Major Competitors
Table 15. Beckman Coulter/Danaher Major Business
Table 16. Beckman Coulter/Danaher Endocrine Testing Product and Solutions
Table 17. Beckman Coulter/Danaher Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Biomedical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 19. Biomedical Diagnostics Major Business
Table 20. Biomedical Diagnostics Endocrine Testing Product and Solutions
Table 21. Biomedical Diagnostics Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 23. BioMerieux Major Business
Table 24. BioMerieux Endocrine Testing Product and Solutions
Table 25. BioMerieux Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 27. Bio-Rad Major Business
Table 28. Bio-Rad Endocrine Testing Product and Solutions
Table 29. Bio-Rad Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Dako Corporate Information, Head Office, and Major Competitors
Table 31. Dako Major Business
Table 32. Dako Endocrine Testing Product and Solutions
Table 33. Dako Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. DiaSorin Corporate Information, Head Office, and Major Competitors
Table 35. DiaSorin Major Business
Table 36. DiaSorin Endocrine Testing Product and Solutions
Table 37. DiaSorin Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Eiken Corporate Information, Head Office, and Major Competitors
Table 39. Eiken Major Business
Table 40. Eiken Endocrine Testing Product and Solutions
Table 41. Eiken Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Fujirebio Corporate Information, Head Office, and Major Competitors
Table 43. Fujirebio Major Business
Table 44. Fujirebio Endocrine Testing Product and Solutions
Table 45. Fujirebio Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Instrumentation Laboratory Corporate Information, Head Office, and Major Competitors
Table 47. Instrumentation Laboratory Major Business
Table 48. Instrumentation Laboratory Endocrine Testing Product and Solutions
Table 49. Instrumentation Laboratory Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Kyowa Medex Corporate Information, Head Office, and Major Competitors
Table 51. Kyowa Medex Major Business
Table 52. Kyowa Medex Endocrine Testing Product and Solutions
Table 53. Kyowa Medex Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Matritech Corporate Information, Head Office, and Major Competitors
Table 55. Matritech Major Business
Table 56. Matritech Endocrine Testing Product and Solutions
Table 57. Matritech Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Ortho-Clinical Diagnostics Corporate Information, Head Office, and Major Competitors
Table 59. Ortho-Clinical Diagnostics Major Business
Table 60. Ortho-Clinical Diagnostics Endocrine Testing Product and Solutions
Table 61. Ortho-Clinical Diagnostics Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Roche Corporate Information, Head Office, and Major Competitors
Table 63. Roche Major Business
Table 64. Roche Endocrine Testing Product and Solutions
Table 65. Roche Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Siemens Corporate Information, Head Office, and Major Competitors
Table 67. Siemens Major Business
Table 68. Siemens Endocrine Testing Product and Solutions
Table 69. Siemens Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. Sysmex Corporate Information, Head Office, and Major Competitors
Table 71. Sysmex Major Business
Table 72. Sysmex Endocrine Testing Product and Solutions
Table 73. Sysmex Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. Thermo Fisher Corporate Information, Head Office, and Major Competitors
Table 75. Thermo Fisher Major Business
Table 76. Thermo Fisher Endocrine Testing Product and Solutions
Table 77. Thermo Fisher Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. Tosoh Corporate Information, Head Office, and Major Competitors
Table 79. Tosoh Major Business
Table 80. Tosoh Endocrine Testing Product and Solutions
Table 81. Tosoh Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Wako Corporate Information, Head Office, and Major Competitors
Table 83. Wako Major Business
Table 84. Wako Endocrine Testing Product and Solutions
Table 85. Wako Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Wallac/PE Corporate Information, Head Office, and Major Competitors
Table 87. Wallac/PE Major Business
Table 88. Wallac/PE Endocrine Testing Product and Solutions
Table 89. Wallac/PE Endocrine Testing Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Global Endocrine Testing Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 91. Global Endocrine Testing Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 92. Breakdown of Endocrine Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 93. Endocrine Testing Players Head Office, Products and Services Provided
Table 94. Endocrine Testing Mergers & Acquisitions in the Past Five Years
Table 95. Endocrine Testing New Entrants and Expansion Plans
Table 96. Global Endocrine Testing Revenue (USD Million) by Type (2017-2022)
Table 97. Global Endocrine Testing Revenue Share by Type (2017-2022)
Table 98. Global Endocrine Testing Revenue Forecast by Type (2023-2028)
Table 99. Global Endocrine Testing Revenue by Application (2017-2022)
Table 100. Global Endocrine Testing Revenue Forecast by Application (2023-2028)
Table 101. North America Endocrine Testing Revenue by Type (2017-2022) & (USD Million)
Table 102. North America Endocrine Testing Revenue by Type (2023-2028) & (USD Million)
Table 103. North America Endocrine Testing Revenue by Application (2017-2022) & (USD Million)
Table 104. North America Endocrine Testing Revenue by Application (2023-2028) & (USD Million)
Table 105. North America Endocrine Testing Revenue by Country (2017-2022) & (USD Million)
Table 106. North America Endocrine Testing Revenue by Country (2023-2028) & (USD Million)
Table 107. Europe Endocrine Testing Revenue by Type (2017-2022) & (USD Million)
Table 108. Europe Endocrine Testing Revenue by Type (2023-2028) & (USD Million)
Table 109. Europe Endocrine Testing Revenue by Application (2017-2022) & (USD Million)
Table 110. Europe Endocrine Testing Revenue by Application (2023-2028) & (USD Million)
Table 111. Europe Endocrine Testing Revenue by Country (2017-2022) & (USD Million)
Table 112. Europe Endocrine Testing Revenue by Country (2023-2028) & (USD Million)
Table 113. Asia-Pacific Endocrine Testing Revenue by Type (2017-2022) & (USD Million)
Table 114. Asia-Pacific Endocrine Testing Revenue by Type (2023-2028) & (USD Million)
Table 115. Asia-Pacific Endocrine Testing Revenue by Application (2017-2022) & (USD Million)
Table 116. Asia-Pacific Endocrine Testing Revenue by Application (2023-2028) & (USD Million)
Table 117. Asia-Pacific Endocrine Testing Revenue by Region (2017-2022) & (USD Million)
Table 118. Asia-Pacific Endocrine Testing Revenue by Region (2023-2028) & (USD Million)
Table 119. South America Endocrine Testing Revenue by Type (2017-2022) & (USD Million)
Table 120. South America Endocrine Testing Revenue by Type (2023-2028) & (USD Million)
Table 121. South America Endocrine Testing Revenue by Application (2017-2022) & (USD Million)
Table 122. South America Endocrine Testing Revenue by Application (2023-2028) & (USD Million)
Table 123. South America Endocrine Testing Revenue by Country (2017-2022) & (USD Million)
Table 124. South America Endocrine Testing Revenue by Country (2023-2028) & (USD Million)
Table 125. Middle East & Africa Endocrine Testing Revenue by Type (2017-2022) & (USD Million)
Table 126. Middle East & Africa Endocrine Testing Revenue by Type (2023-2028) & (USD Million)
Table 127. Middle East & Africa Endocrine Testing Revenue by Application (2017-2022) & (USD Million)
Table 128. Middle East & Africa Endocrine Testing Revenue by Application (2023-2028) & (USD Million)
Table 129. Middle East & Africa Endocrine Testing Revenue by Country (2017-2022) & (USD Million)
Table 130. Middle East & Africa Endocrine Testing Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Endocrine Testing Picture
Figure 2. Global Endocrine Testing Revenue Market Share by Type in 2021
Figure 3. Tandem Mass Spectrometry
Figure 4. Immunoassay
Figure 5. Endocrine Testing Revenue Market Share by Application in 2021
Figure 6. Hospitals Picture
Figure 7. Commercial Laboratories Picture
Figure 8. Ambulatory Care Centres Picture
Figure 9. Other Setting Picture
Figure 10. Global Endocrine Testing Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Endocrine Testing Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Endocrine Testing Revenue Market Share by Region (2017-2028)
Figure 13. Global Endocrine Testing Revenue Market Share by Region in 2021
Figure 14. North America Endocrine Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Endocrine Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Endocrine Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Endocrine Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Endocrine Testing Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Endocrine Testing Market Drivers
Figure 20. Endocrine Testing Market Restraints
Figure 21. Endocrine Testing Market Trends
Figure 22. Abbott Laboratories Recent Developments and Future Plans
Figure 23. AdnaGen Recent Developments and Future Plans
Figure 24. Beckman Coulter/Danaher Recent Developments and Future Plans
Figure 25. Biomedical Diagnostics Recent Developments and Future Plans
Figure 26. BioMerieux Recent Developments and Future Plans
Figure 27. Bio-Rad Recent Developments and Future Plans
Figure 28. Dako Recent Developments and Future Plans
Figure 29. DiaSorin Recent Developments and Future Plans
Figure 30. Eiken Recent Developments and Future Plans
Figure 31. Fujirebio Recent Developments and Future Plans
Figure 32. Instrumentation Laboratory Recent Developments and Future Plans
Figure 33. Kyowa Medex Recent Developments and Future Plans
Figure 34. Matritech Recent Developments and Future Plans
Figure 35. Ortho-Clinical Diagnostics Recent Developments and Future Plans
Figure 36. Roche Recent Developments and Future Plans
Figure 37. Siemens Recent Developments and Future Plans
Figure 38. Sysmex Recent Developments and Future Plans
Figure 39. Thermo Fisher Recent Developments and Future Plans
Figure 40. Tosoh Recent Developments and Future Plans
Figure 41. Wako Recent Developments and Future Plans
Figure 42. Wallac/PE Recent Developments and Future Plans
Figure 43. Global Endocrine Testing Revenue Share by Players in 2021
Figure 44. Endocrine Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 45. Global Top 3 Players Endocrine Testing Revenue Market Share in 2021
Figure 46. Global Top 10 Players Endocrine Testing Revenue Market Share in 2021
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 48. Global Endocrine Testing Revenue Share by Type in 2021
Figure 49. Global Endocrine Testing Market Share Forecast by Type (2023-2028)
Figure 50. Global Endocrine Testing Revenue Share by Application in 2021
Figure 51. Global Endocrine Testing Market Share Forecast by Application (2023-2028)
Figure 52. North America Endocrine Testing Sales Market Share by Type (2017-2028)
Figure 53. North America Endocrine Testing Sales Market Share by Application (2017-2028)
Figure 54. North America Endocrine Testing Revenue Market Share by Country (2017-2028)
Figure 55. United States Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Canada Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Mexico Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Europe Endocrine Testing Sales Market Share by Type (2017-2028)
Figure 59. Europe Endocrine Testing Sales Market Share by Application (2017-2028)
Figure 60. Europe Endocrine Testing Revenue Market Share by Country (2017-2028)
Figure 61. Germany Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. France Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. United Kingdom Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Russia Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Italy Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Asia-Pacific Endocrine Testing Sales Market Share by Type (2017-2028)
Figure 67. Asia-Pacific Endocrine Testing Sales Market Share by Application (2017-2028)
Figure 68. Asia-Pacific Endocrine Testing Revenue Market Share by Region (2017-2028)
Figure 69. China Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Japan Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South Korea Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. India Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Southeast Asia Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Australia Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South America Endocrine Testing Sales Market Share by Type (2017-2028)
Figure 76. South America Endocrine Testing Sales Market Share by Application (2017-2028)
Figure 77. South America Endocrine Testing Revenue Market Share by Country (2017-2028)
Figure 78. Brazil Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Argentina Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Middle East and Africa Endocrine Testing Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Endocrine Testing Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Endocrine Testing Revenue Market Share by Country (2017-2028)
Figure 83. Turkey Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Saudi Arabia Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. UAE Endocrine Testing Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source